Xvivo Perfusion AB (publ)
STO: XVIVO.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Christoffer Rosenblad
- Employees
- 193
- Headquarters
- Gothenburg, Sweden
- IPO year
- 2012
- Market cap
- SEK 9.0B
- Website
- https://www.xvivoperfusion.com
Loading XVIVO…
Loading profile data…Frequently asked questions about XVIVO
What does Xvivo Perfusion AB (publ) (XVIVO.ST) do?
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-sh...
Where does XVIVO.ST trade?
Xvivo Perfusion AB (publ) (XVIVO.ST) trades on the Stockholm Stock Exchange.
What sector is XVIVO.ST in?
Xvivo Perfusion AB (publ) (XVIVO.ST) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Xvivo Perfusion AB (publ)?
Christoffer Rosenblad is the chief executive officer of Xvivo Perfusion AB (publ) (XVIVO.ST).
Where is Xvivo Perfusion AB (publ) headquartered?
Xvivo Perfusion AB (publ) is headquartered in Sweden.
Does XVIVO.ST pay a dividend?
Xvivo Perfusion AB (publ) (XVIVO.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XVIVO.ST go public?
Xvivo Perfusion AB (publ) (XVIVO.ST) completed its initial public offering in 2012.